Morgan Stanley A Tyr Pharma Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Morgan Stanley holds 1 shares of LIFE stock, worth $1. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 1 -0.0%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 17, 2024	SELL	$0.0 - $2.07 $0 - $40,814	-19,717 Reduced 99.99%	1 $0
Q2 2024 Aug 14, 2024	SELL	$0.0 - $2.07 $0 - $40,814	-19,717 Reduced 99.99%	1 $0
Q1 2024 Oct 17, 2024	BUY	$1.42 - $2.02 $27,998 - $39,828	19,717 Added 1971700.0%	19,718 $38,000
Q1 2024 Aug 16, 2024	BUY	$1.42 - $2.02 $5,388 - $7,665	3,795 Added 23.83%	19,718 $38,000
Q1 2024 May 15, 2024	BUY	$1.42 - $2.02 $5,388 - $7,665	3,795 Added 23.83%	19,718 $38,000
Q4 2023 Aug 16, 2024	BUY	$1.11 - $1.51 $17,673 - $24,042	15,922 Added 1592200.0%	15,923 $22,000
Q4 2023 Feb 13, 2024	BUY	$1.11 - $1.51 $15,006 - $20,413	13,519 Added 562.35%	15,923 $22,000
Q3 2023 Nov 15, 2023	SELL	$1.55 - $2.23 $79 - $113	-51 Reduced 2.08%	2,404 $3,000
Q2 2023 Aug 14, 2023	BUY	$1.72 - $2.57 $294 - $439	171 Added 7.49%	2,455 $5,000
Q1 2023 May 15, 2023	BUY	$1.88 - $2.5 $4,293 - $5,710	2,284 New	2,284 $4,000
Q2 2022 Aug 15, 2022	SELL	$2.63 - $5.61 $189 - $403	-72 Closed	0 $0
Q1 2022 Oct 27, 2022	BUY	$4.75 - $7.54 $342 - $542	72 New	72 $0
Q1 2022 May 13, 2022	SELL	$4.75 - $7.54 $96,866 - $153,763	-20,393 Reduced 99.65%	72 $0
Q4 2021 Feb 14, 2022	BUY	$7.29 - $9.5 $149,189 - $194,417	20,465 New	20,465 $153,000

Others Institutions Holding LIFE

# of Institutions

Shares Held

37.1M

Call Options Held

30.2K

Put Options Held

3.1K

Federated Hermes, Inc. Pittsburgh, PA

14.7M
Shares

$27.3 Million
0.06% of portfolio
Vanguard Group Inc Valley Forge, PA

2.99M
Shares

$5.56 Million
0.0% of portfolio
Tikvah Management LLC Charlotte, NC

2.46M
Shares

$4.58 Million
1.45% of portfolio
Logos Global Management LP San Francisco, CA

2M
Shares

$3.72 Million
0.49% of portfolio
Checkpoint Capital L.P. San Francisco, CA

1.74M
Shares

$3.23 Million
1.52% of portfolio

View Full List

About aTYR PHARMA INC

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

More about LIFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account